{"cdcTestId":"2022-0039","testcaseName":"Patient is 3 years of age and has been administered a third dose of a Covid-19 vaccine at 8 weeks - 5 days","vaccineGroup":"COVID-19","evaluationTestType":"Interval: Below Absolute Minimum","forecastTestType":"Recommended based on minimum interval from invalid dose","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2019-07-13T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-07-13T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-03T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-23T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}]},"forecast":{"forecastNum":"3","earliestDate":"2022-11-18T00:00:00","recommendedDate":"2022-11-18T00:00:00","pastDueDate":"0001-01-01T00:00:00"},"doses":[{"dateAdministered":"2022-07-13T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-08-03T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null},{"dateAdministered":"2022-09-23T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"219","mvx":"PFR","evaluationStatus":"Not Valid","evaluationReason":"Interval: too short"}],"dateAdded":"2022-05-16T20:00:00","dateUpdated":"2022-06-27T08:12:19.938","generalDescription":"This test case describes when a patient that is 3 years of age has been administered the third dose of a Covid-19 (CVX 219) vaccine at 8 weeks - 5 days that the dose is not valid.  A repeat dose should be forecast.","changedInVersion":"4.24","reasonForChange":""}